Shandong, China

Shengbiao Wan

This inventor holds 1 USPTO granted patent. Top assignee: Ocean University of China. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shengbiao Wan. Retrieved from https://idiyas.com/inventor/shengbiao-wan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Shengbiao Wan in Lymph Targeting Nuclear Magnetic Contrast Agents

Introduction

Shengbiao Wan is a notable inventor based in Shandong, China. He has made significant contributions to the field of medical imaging, particularly in the development of contrast agents for nuclear magnetic resonance imaging. His innovative work focuses on enhancing the visualization of lymphatic tissues, which is crucial for diagnosing various lymph system diseases.

Latest Patents

Shengbiao Wan holds a patent for a "Lymph targeting nuclear magnetic contrast agent using brown algae polysaccharide as carrier and preparation method and use thereof." This patent describes a novel contrast agent that utilizes brown algae polysaccharide as a carrier, combined with mannose or its derivatives to improve binding to lymphoid tissues. The resulting macromolecular contrast agent exhibits excellent water solubility and significantly enhances the visualization of lymph vessels and lymph nodes during MRI scans. This advancement is vital for the accurate detection and diagnosis of lymphatic diseases.

Career Highlights

Shengbiao Wan is affiliated with Ocean University of China, where he conducts research and development in the field of medical imaging. His work has led to advancements that improve the effectiveness of diagnostic imaging techniques, particularly in relation to lymphatic system disorders. His innovative approach to using natural polysaccharides as carriers for contrast agents showcases his commitment to integrating biocompatible materials in medical applications.

Collaborations

Shengbiao Wan has collaborated with notable colleagues, including Tao Jiang and Wei Shang. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in the field of medical imaging.

Conclusion

Shengbiao Wan's contributions to the development of lymph targeting nuclear magnetic contrast agents represent a significant advancement in medical imaging technology. His innovative approach not only improves diagnostic capabilities but also highlights the potential of using natural materials in medical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…